Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC.ZBH · Entity 3278 | Group President, Asia Pacific | May 29, 2026 | June 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ZIMMER BIOMET HOLDINGS, INC.
Report date May 29, 2026 · Filed June 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,251 |
Ending reported balance
After 2026-05-29 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-29 · Sale · Disposed 4,200 · Balance 28,051 Row 2 · 2026-05-29 · Sale · Disposed 800 · Balance 27,251 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 29, 2026 Filed Jun 2, 2026 20:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 800 | $82.66 | $66,128.00 |
DisclosureSEC source: 0001635943-26-000013 · form4-06022026_080619.xml · nonDerivative · entry 2 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,251 Read SEC document |
| May 29, 2026 Filed Jun 2, 2026 20:35 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 4,200 | $82.64 | $347,088.00 |
DisclosureSEC source: 0001635943-26-000013 · form4-06022026_080619.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,051 Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:08 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 2,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001635943-26-000010 · form4-03102026_080309.xml · derivative · entry 4 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,364 shares Expires 2026-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:08 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 7,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001635943-26-000010 · form4-03102026_080309.xml · derivative · entry 3 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,050 shares Expires 2026-03-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:08 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 2,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001635943-26-000010 · form4-03102026_080309.xml · nonDerivative · entry 2 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,251 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 20:08 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 7,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001635943-26-000010 · form4-03102026_080309.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,887 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:05 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 2,785 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001635943-26-000008 · form4-02272026_090254.xml · derivative · entry 2 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,567 Underlying: Common Stock · 2,785 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One-third of the RSUs vested on February 25, 2026. The remaining RSUs vest one-half on each of February 25, 2027 and February 25, 2028. F1 · derivative.expiration_date: One-third of the RSUs vested on February 25, 2026. The remaining RSUs vest one-half on each of February 25, 2027 and February 25, 2028. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:05 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 2,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001635943-26-000008 · form4-02272026_090254.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,837 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 02:01 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 9,043 | $0.00 | $0.00 |
DisclosureSEC source: 0001635943-26-000006 · form4-02252026_020249.xml · derivative · entry 3 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,043 Underlying: Common Stock · 9,043 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2027. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 02:01 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 2,382 | $0.00 | $0.00 |
DisclosureSEC source: 0001635943-26-000006 · form4-02252026_020249.xml · derivative · entry 2 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,382 Underlying: Common Stock · 2,382 shares Expires 2026-02-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 02:01 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 2,382 | $0.00 | $0.00 |
DisclosureSEC source: 0001635943-26-000006 · form4-02252026_020249.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 22:32 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 7,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001635943-26-000004 · form4-02232026_100224.xml · derivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,050 Underlying: Common Stock · 7,050 shares Expires 2026-03-06 F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · shares: On March 6, 2023, and on September 1, 2023, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2023 - 2025. As determined on February 19, 2026, based on actual performance, the reporting person earned 5,298 RSUs for March and 1,752 RSUs for September, totaling 7,050 RSUs, which will vest on March 6, 2026. F2 · derivative.underlying_shares: On March 6, 2023, and on September 1, 2023, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2023 - 2025. As determined on February 19, 2026, based on actual performance, the reporting person earned 5,298 RSUs for March and 1,752 RSUs for September, totaling 7,050 RSUs, which will vest on March 6, 2026. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:07 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 1,000 | $96.49 | $96,490.00 |
DisclosureSEC source: 0001635943-26-000002 · form4-02172026_090203.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,670 F1 · balance_after: Includes 86 shares acquired under the Employee Stock Purchase Plan on December 31, 2025. Read SEC document |
| September 11, 2025 Filed Sep 15, 2025 20:08 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 1,200 | $103.59 | $124,302.00 |
DisclosureSEC source: 0001635943-25-000004 · form4-09152025_080944.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,584 F1 · balance_after: Includes 160 shares acquired under the Employee Stock Purchase Plan on June 30, 2025. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:06 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 800 | $92.51 | $74,011.20 |
DisclosureSEC source: 0001062993-25-011810 · form4.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,624 Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 20:39 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 1,000 | $95.00 | $95,000.00 |
DisclosureSEC source: 0001062993-25-011674 · form4.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,424 Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:32 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 2,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004968 · form4.xml · derivative · entry 2 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,364 Underlying: Common Stock · 2,365 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: 2,365 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026 F2 · derivative.expiration_date: 2,365 of the RSUs vested on March 6, 2025. The remaining RSUs vest on March 6, 2026 Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:32 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 2,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-004968 · form4.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,424 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2025 Filed Feb 28, 2025 02:33 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 8,352 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003852 · form4.xml · derivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,352 Underlying: Common Stock · 8,352 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 25, 2026. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 25, 2026. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:05 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 2,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003332 · form4.xml · derivative · entry 2 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,764 Underlying: Common Stock · 2,383 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F2 · derivative.exercise_date: One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027. F2 · derivative.expiration_date: One-third of the RSUs vested on February 20, 2025. The remaining RSUs vest one-half on each of February 20, 2026 and February 20, 2027. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:05 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 2,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003332 · form4.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 23:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 11,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-002917 · form4.xml · derivative · entry 3 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,138 shares Expires 2025-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Zimmer Biomet Holdings, Inc. (the "Company"). Read SEC document |
| February 18, 2025 Filed Feb 19, 2025 23:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 11,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-002917 · form4.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 216 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment through February 18, 2025. Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 23:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 11,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-002917 · form4.xml · derivative · entry 2 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,138 Underlying: Common Stock · 11,138 shares Expires 2025-02-18 F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Zimmer Biomet Holdings, Inc. (the "Company"). F3 · shares: On February 18, 2022, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2022 - 2024. As determined on February 14, 2025, based on actual performance, the reporting person earned 11,138 RSUs, which vested on February 18, 2025 F3 · derivative.underlying_shares: On February 18, 2022, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2022 - 2024. As determined on February 14, 2025, based on actual performance, the reporting person earned 11,138 RSUs, which vested on February 18, 2025 Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:21 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 12,857 | $114.69 | $1,474,582.19 |
DisclosureSEC source: 0001062993-24-011819 · form4.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,322 F1 · price: Reflects the weighted average price of 12,857 common shares sold by the reporting person in multiple transactions on May 31, 2024 with sale prices ranging from $114.64 to 114.79 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 22:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,705 | $0.00 Strike: $91.53 | $0.00 |
DisclosureSEC source: 0001062993-24-006020 · form4.xml · derivative · entry 5 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,705 shares Expires 2024-03-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 22:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 1,705 | $126.86 | $216,296.30 |
DisclosureSEC source: 0001062993-24-006020 · form4.xml · nonDerivative · entry 3 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,179 Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 22:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 1,705 | $91.53 | $156,058.65 |
DisclosureSEC source: 0001062993-24-006020 · form4.xml · nonDerivative · entry 2 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,884 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 2,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-006020 · form4.xml · derivative · entry 4 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,729 Underlying: Common Stock · 2,365 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026. F2 · derivative.expiration_date: One-third of the RSUs vested on March 6, 2024. The remaining RSUs vest one-half on each of March 6, 2025 and March 6, 2026. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 22:03 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 2,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-006020 · form4.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:59 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 2,052 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005553 · form4.xml · derivative · entry 2 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,052 shares Expires 2024-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:59 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 2,052 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-005553 · form4.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,814 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:55 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 5,047 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004684 · form4.xml · derivative · entry 2 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,047 shares Expires 2024-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. Read SEC document |
| February 25, 2024 Filed Feb 28, 2024 01:55 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 5,047 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004684 · form4.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,762 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. F2 · balance_after: Includes 188 shares acquired under the Company's Employee Stock Purchase Plan and pursuant to dividend reinvestment through February 1, 2024. Read SEC document |
| February 20, 2024 Filed Feb 23, 2024 02:01 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 7,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-004135 · form4.xml · derivative · entry 1 Yi Sang · CIK 0001635943 · Group President, Asia Pacific 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,147 Underlying: Common Stock · 7,147 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing February 20, 2025. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:26 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 7,094 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-006284 · form4.xml · derivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,094 Underlying: Common Stock · 7,094 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024. F2 · derivative.expiration_date: Vests annually over three years in increments of one-third each year, commencing March 6, 2024. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 22:55 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 2,423 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-004635 · form4.xml · derivative · entry 2 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,423 shares Expires 2023-02-21 F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock. F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 22:55 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 2,423 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-004635 · form4.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,527 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This number of restricted stock units ("RSUs") reflects the adjustments that occurred as of March 1, 2022 in connection with Zimmer Biomet Holdings, Inc.'s (the "Company") spinoff of Zimvie Inc. In connection with the spinoff, each RSU was adjusted to preserve the intrinsic value of such award by multiplying it by an equity exchange ratio, rounded up to the nearest whole unit, which adjustments were made following the initial reporting of these RSUs. F2 · balance_after: Includes 268 shares acquired under the Company's Employee Stock Purchase Plan and pursuant to dividend reinvestment through February 2, 2023. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:07 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 2,052 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006637 · form4.xml · derivative · entry 3 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,052 Underlying: Common Stock · 2,052 shares Expires 2024-03-01 F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:07 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 4,895 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006637 · form4.xml · derivative · entry 2 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,895 Underlying: Common Stock · 4,895 shares Expires 2024-02-25 F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · shares: In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units ("PRSUs") held by Company employees, included the reporting person, were converted into time-based RSUs. Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level. The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed. F2 · derivative.underlying_shares: In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units ("PRSUs") held by Company employees, included the reporting person, were converted into time-based RSUs. Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level. The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed. F2 · balance_after: In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units ("PRSUs") held by Company employees, included the reporting person, were converted into time-based RSUs. Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level. The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:07 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 2,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006637 · form4.xml · derivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,350 Underlying: Common Stock · 2,350 shares Expires 2023-02-21 F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · shares: In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units ("PRSUs") held by Company employees, included the reporting person, were converted into time-based RSUs. Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level. The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed. F2 · derivative.underlying_shares: In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units ("PRSUs") held by Company employees, included the reporting person, were converted into time-based RSUs. Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level. The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed. F2 · balance_after: In connection with the Company's spinoff of ZimVie Inc., certain performance-based restricted stock units ("PRSUs") held by Company employees, included the reporting person, were converted into time-based RSUs. Effective as of March 1, 2022, PRSU awards granted in 2020 were converted into RSUs at a 50% payout level and PRSU awards granted in 2021 were converted into RSUs at an 82.5% payout level. The vesting date of these awards remains the same, with the RSUs converted from 2020 PRSUs and 2021 PRSUs scheduled to vest on February 21, 2023 and February 25, 2024, respectively. Further, in connection with the spinoff, the RSUs will be adjusted pursuant to an exchange ratio, in order to preserve the intrinsic value of the original award. The RSUs reported on this Form 4 reflect the number of RSUs following conversion from PRSUs, but do not reflect the exchange ratio adjustment, as such calculations have not yet been completed. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 22:01 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 25,782 | $0.00 Strike: $120.82 | $0.00 |
DisclosureSEC source: 0001062993-22-005361 · form4.xml · derivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,782 Underlying: Common Stock · 25,782 shares Expires 2032-02-18 F1 · derivative.exercise_date: Vests annually over three years in increments of one-third each year, commencing on February 18, 2023. Read SEC document |
| December 14, 2021 Filed Dec 15, 2021 23:04 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 200 | $124.18 | $24,835.00 |
DisclosureSEC source: 0001062993-21-012954 · form4.xml · nonDerivative · entry 2 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,837 Read SEC document |
| December 14, 2021 Filed Dec 15, 2021 23:04 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 2,600 | $124.14 | $322,764.00 |
DisclosureSEC source: 0001062993-21-012954 · form4.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,037 F1 · balance_after: Includes 96 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan on June 30, 2021. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:40 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 338 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-002187 · form4.xml · derivative · entry 2 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 338 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F3 · derivative.exercise_date: Earned RSUs vested on February 26, 2021. F3 · derivative.expiration_date: Earned RSUs vested on February 26, 2021. Read SEC document |
| February 26, 2021 Filed Mar 2, 2021 23:40 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionCommon Stock | 338 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-002187 · form4.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 58 shares acquired under the Zimmer Biomet Holdings, Inc. (the ???Company???) Employee Stock Purchase Plan and pursuant to dividend reinvestment between August 4, 2020 and February 2, 2021. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:55 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantEmployee Stock Option (right to buy) · Derivative | 24,305 | $0.00 Strike: $163.79 | $0.00 |
DisclosureSEC source: 0001062993-21-002096 · form4.xml · derivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,305 Underlying: Common Stock · 24,305 shares Expires 2031-02-25 F1 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on February 25, 2022. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 22:06 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | GrantRestricted Stock Units · Derivative | 338 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-001862 · form4.xml · derivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338 Underlying: Common Stock · 338 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock. F2 · shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 338 RSUs. F3 · derivative.exercise_date: Earned RSUs will vest on February 26, 2021. F3 · derivative.expiration_date: Earned RSUs will vest on February 26, 2021. F2 · derivative.underlying_shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 338 RSUs. F2 · balance_after: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 338 RSUs. Read SEC document |
| November 18, 2020 Filed Nov 20, 2020 21:27 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | SaleCommon Stock | 1,200 | $152.59 | $183,108.00 |
DisclosureSEC source: 0001062993-20-005831 · form4.xml · nonDerivative · entry 1 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,145 F1 · balance_after: Includes 122 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan on July 9, 2020. Read SEC document |
| June 07, 2020 Filed Jun 9, 2020 21:11 UTC | ZIMMER BIOMET HOLDINGS, INC. ZBH · Entity 3278 | Exercise / conversionRestricted Stock Units · Derivative | 6,717 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-20-000129 · edgar.xml · derivative · entry 2 Yi Sang · CIK 0001635943 · President, Asia Pacific 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,717 shares Expires 2020-06-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Zimmer Biomet Holdings, Inc's common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.